Individualized Pharmaceutical Care for One Patient with End-stage Renal Disease and Atrial Fibrillation after Aortic Valve Replacement
- VernacularTitle:1例心脏瓣膜置换术后合并房颤的终末期肾病患者个体化用药监护
- Author:
Qiaoxue PU
;
Zhen LIU
- Keywords:
Pharmaceutical care;
Chronic kidney disease;
Digoxin;
Drug concentration;
Warfarin;
International normalized ratio
- From:
China Pharmacist
2017;20(4):683-686
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the importance and the breakthrough points of pharmaceutical care for patients with renal disease,especially using drugs with narrow therapeutic window and notable individual difference.Methods:Digoxin concentration and international normalized ratio (INR) were detected by clinical pharmacists,and then individualized pharmaceutical care was given to the patient according to the monitoring results.Results:Physician increased the monitoring frequency and adjusted the drug usage according to the patient's renal function.The patient's condition was improved and understood the necessity of related index monitoring.Conclusion:Clinical pharmacists can assist physicians in optimizing the treatment,and ensure safe,reasonable and effective medication by providing pharmaceutical care in various aspects.
